scholarly journals Pollen Specificity Elements Reside in 30 bp of the Proximal Promoters of Two Pollen-Expressed Genes

1995 ◽  
Vol 7 (3) ◽  
pp. 373
Author(s):  
Yoram Eyal ◽  
Catherine Curie ◽  
Sheila McCormick
Keyword(s):  
2008 ◽  
Vol 190 (10) ◽  
pp. 3456-3466 ◽  
Author(s):  
Christelle Bahlawane ◽  
Birgit Baumgarth ◽  
Javier Serrania ◽  
Silvia Rüberg ◽  
Anke Becker

ABSTRACT Depending on the phosphate concentration encountered in the environment Sinorhizobium meliloti 2011 synthesizes two different exopolysaccharides (EPS). Galactoglucan (EPS II) is produced under phosphate starvation but also in the presence of extra copies of the transcriptional regulator WggR (ExpG) or as a consequence of a mutation in mucR. The galactoglucan biosynthesis gene cluster contains the operons wga (expA), wge (expE), wgd (expD), and wggR (expG). Two promoters, differentially controlled by WggR, PhoB, and MucR, were identified upstream of each of these operons. The proximal promoters of the wga, wge, and wgd transcription units were constitutively active when separated from the upstream regulatory sequences. Promoter activity studies and the positions of predicted PhoB and WggR binding sites suggested that the proximal promoters are cooperatively induced by PhoB and WggR. MucR was shown to strongly inhibit the distal promoters and bound to the DNA in the vicinity of the distal transcription start sites. An additional inhibitory effect on the distal promoter of the structural galactoglucan biosynthesis genes was identified as a new feature of WggR in a mucR mutant. A regulatory model of the fine-tuning of galactoglucan production is proposed.


2012 ◽  
Vol 108 (09) ◽  
pp. 419-426 ◽  
Author(s):  
Richard J. Fish ◽  
Marguerite Neerman-Arbez

SummaryThe Aα, Bβ and γ polypeptide chains of fibrinogen are encoded by a three gene cluster on human chromosome four. The fibrinogen genes (FGB-FGA-FGG) are expressed almost exclusively in hepatocytes where their output is coordinated to ensure a sufficient mRNA pool for each chain and maintain an abundant plasma fibrinogen protein level. Fibrinogen gene expression is controlled by the activity of proximal promoters which contain binding sites for hepatocyte transcription factors, including proteins which influence fibrinogen transcription in response to acute-phase inflammatory stimuli. The fibrinogen gene cluster also contains cis regulatory elements; enhancer sequences with liver activities identified by sequence conservation and functional genomics. While the transcriptional control of this gene cluster is fascinating biology, the medical impetus to understand fibrinogen gene regulation stems from the association of cardiovascular disease risk with high level circulating fibrinogen. In the general population this level varies from about 1.5 to 3.5 g/l. This variation between individuals is influenced by genotype, suggesting there are genetic variants contributing to fibrinogen levels which reside in fibrinogen regulatory loci. A complete picture of how fibrinogen genes are regulated will therefore point towards novel sources of regulatory variants. In this review we discuss regulation of the fibrinogen genes from proximal promoters and enhancers, the influence of acute-phase stimulation, post-transcriptional regulation by miRNAs and functional regulatory variants identified in genetic studies. Finally, we discuss the fibrinogen locus in light of recent advances in understanding chromosomal architecture and suggest future directions for researching the mechanisms that control fibrinogen expression.


2003 ◽  
Vol 35 (8) ◽  
pp. 1272-1283 ◽  
Author(s):  
Jamie Monslow ◽  
John D. Williams ◽  
Nadine Norton ◽  
Carol A. Guy ◽  
Iain K. Price ◽  
...  

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 1120-1120
Author(s):  
Kevin Petrie ◽  
Louise Howell ◽  
Estella Matutes ◽  
Samuel Waxman ◽  
Miguel Angel Piris ◽  
...  

Abstract Histone deacetylases (HDACs) perform key functions in transcriptional regulation by modifying the core histones of the nucleosome as well as non-histone targets. We have previously cloned and characterized HDAC9, a member of the Class IIa HDAC family, which also contains HDACs 4,5 and 7. These are characterized by the presence of a common N-terminal region, which mediates direct interactions with transcription factors such as BCL-6 or MEF2. The HDAC9 gene encodes multiple protein isoforms some of which display distinct cellular localization patterns and biological activities. The transcribed region of HDAC9 is very large, spanning more than 900 kilobases, with approximately 50% of these sequences being non-coding. Consistent with its size as well as the multiplicity and structural complexity of expressed HDAC9 isoforms, we report that HDAC9 expression is under the control of three independent promoter regions, one of which possesses a CpG island. This is in contrast to other HDAC genes thus far identified, each of which appears to possess a single CpG island-containing promoter. Transcripts initiating from the individual HDAC9 promoters are differentially expressed and encode specific HDAC9 isoforms. A comparison of the human and mouse HDAC9 genes reveals some important differences in both regulatory regions and coding sequences. Specifically, the human HDAC9 gene can express from its second promoter, which is not present in the mouse gene, hematopoietic-specific transcripts (i.e. only found in the lymph node, spleen and lymphocytes in normal tissue) that encode isoforms containing previously unidentified N-terminal sequences. In normal B cells, HDAC9 mRNA transcripts are initiated from the second and proximal promoters and stimulation of these cells with IL2, α-CD40 MoAb, Staphylococcus aureus Cowan strain 1, or arsenic trioxide had no appreciable affect on HDAC9 expression. However, due to a potentially abnormal differential promoter usage and alternative splicing, chronic lymphocytic leukemia (CLL) patient B-cells displayed HDAC9 isoform expression pattern that was dramatically distinct from that observed in normal B-cells. Specifically, there was significant expression from the distal (CpG island containing) promoter, which is not utilised in normal B cells, and overexpression from the second and proximal promoters. With regard to alternative splicing, the CLL patient cells lacked exon7, which contains a nuclear localization signal and exon12, which contains a site of sumoylation - a modification linked to deacetylase activity. Moreover, these changes were specific for full-length HDAC9, and not the MITR isoform that lacks catalytic domain. Stimulation of CLL patient B-cells with SAC/IL-2 caused a switch in promoter usage leading to the change in isoform specific expression to a pattern that is identical to that of normal B-cells. These results suggest that deregulation of HDAC9 expression may play a role in B-cell development and the pathogenesis of B-cell neoplasms. Given the need for development of better therapies for indolent B-cell malignancies such as CLL, the finding that HDAC9 expression in cancer cells is modulated by SAC/IL-2 points to a possible combinatorial therapy with HDAC inhibitors, which have been shown to induce apoptosis in CLL cells.


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 3868-3868
Author(s):  
Laurie A. Steiner ◽  
Yelena Maksimova ◽  
Vincent Schulz ◽  
Patrick G. Gallagher

Abstract Abstract 3868 Insulators are DNA sequences and associated binding proteins that establish and/or maintain boundaries between regions of active and silenced chromatin domains. In higher organisms, there are 2 types of insulators, enhancer-blocking insulators, which establish chromatin domains to separate enhancers and promoters, and barrier insulators, which create a barrier to protect against heterochromatin-mediated gene silencing. Despite their role as critical regulators of tissue-specific gene expression, barrier insulators are poorly understood in mammalian cells, with much of our knowledge from studies of the barrier insulator in the chicken β-globin locus, cHS4. The DNA region of cHS4 that functions as a barrier binds upstream stimulatory factor (USF) proteins that recruit histone methyltransferase (HMT) activity, and histone acetyltransferase (HAT) activity, supporting a model that recruitment of enzymes and other proteins associated with activating histone modifications block the mechanism(s) that lead to spreading of gene-silencing. Our goal is to identify a regulatory signature associated with barrier insulators in erythroid cells. We utilized chromatin immunoprecipitation coupled with ultrahigh throughput Solexa sequencing (ChIP-seq) to generate genome-wide maps of regulatory and chromatin modifying proteins in erythroid cells. To generate cells for ChIP, human CD34+ cells were cultured in serum free media with erythropoietin to yield a population of CD71+/GPA+ erythroid cells (R3/R4 population). First, a genome-wide map of USF1 and USF2 occupancy in primary erythroid cells was created. A total of 19213 USF1 and 20115 USF2 sites of occupancy were identified. USF1 and USF2 frequently heterodimerize; co-localization was present at 15882 sites (83% of USF1 and 79% of USF2 sites). USF heterodimers were commonly located near proximal promoters (within 1KB of TSS, 48% of sites) and enhancers (>1kb from RefSeq gene, 30% of sites). To analyze co-localizing barrier-associated arginine methyltransferases from erythroid cells, ChIP-seq was performed with PRMT1 and PRMT4/CARM1. A total of 7062 PRMT1 sites and 15900 PRMT4 sites were identified. PRMT1 and PRMT4 were commonly found at sites of USF occupancy, with 6120 sites demonstrating occupancy of all four factors, consistent with the hypothesis that the USF proteins frequently recruit HMT's in mammalian cells. Sites of PRMT/USF co-occupancy were more likely to be at proximal promoters (68%) than sites of USF occupancy alone. Genome-wide occupancy of four acetyltransferases commonly found in erythroid cells, CBP, p300, PCAF, and SRC1, was also studied using ChIP-seq. 6804, 46932, 25688, and 25833 sites of occupancy were found for CBP, p300, PCAF, and SRC1 respectively. Co-localization with the p300, PCAF, and SRC1 with the USF/PRMT binding sites was common, occurring in 3825 sites. These sites were most commonly located near proximal promoters (71%) and enhancers (17%). In contrast, CBP co-localized with the USF/PRMT/p300/PCAF/SRC regions in only 10 locations and sites of CBP occupancy were more commonly found at enhancers (64%) and introns (29%) than at promoters (0.4%). Detection of barrier insulators near gene promoters is not surprising. Recent studies have revealed many similarities between barriers and promoters, including binding of specific transcription factors, and have led to the suggestion that barrier insulators have evolved as specialized derivatives of gene promoters, each with specific, yet discrete function. The regulatory protein CTCF mediates enhancer-blocking insulator activity. ChIP-seq was utilized to create a genome-wide map of CTCF binding in erythroid cells. 38503 sites of CTCF occupancy were identified. These sites were located at enhancers (41%), introns, (28%) and proximal promoters (18%). 4459 CTCF sites (12%) co-localized with regions of USF/PRMT/p300/PCAF/SRC binding. These sites most commonly occurred at promoters (65%) and enhancers (19%). The role of CTCF in barrier insulator function is controversial; our data are consistent with recent data demonstrating its mark at chromatin boundaries. The signature composed of USF/PRMT/p300/PCAF/SRC/CTCF was found in the well characterized functional erythroid barrier located in the ankyrin-1 gene proximal promoter region. These data indicate that a common regulatory signature is likely associated with barrier elements in erythroid cells. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document